{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T16:25:15Z","timestamp":1794414315477,"version":"4.9.1"},"publisher-location":"New York, NY","reference-count":165,"publisher":"Springer US","isbn-type":[{"value":"9781461406525","type":"print"},{"value":"9781461406532","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/978-1-4614-0653-2_16","type":"book-chapter","created":{"date-parts":[[2012,3,12]],"date-time":"2012-03-12T08:35:13Z","timestamp":1331541313000},"page":"205-221","source":"Crossref","is-referenced-by-count":56,"title":["Mitochondrial Importance in Alzheimer\u2019s, Huntington\u2019s and Parkinson\u2019s Diseases"],"prefix":"10.1007","author":[{"given":"S\u00f3nia C.","family":"Correia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato X.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongwei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula I.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"16_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1471-4159.2009.06443.x","volume":"112","author":"SC Correia","year":"2010","unstructured":"Correia SC, Moreira PI. Hypoxia-inducible factor 1: a new hope to counteract neurodegeneration? J Neurochem 2010; 112:1\u201312.","journal-title":"J Neurochem"},{"key":"16_CR2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1172\/JCI200317522","volume":"111","author":"S Przedborski","year":"2003","unstructured":"Przedborski S, Vila M, Jackson-Lewis V. Neurodegeneration: what is it and where are we? J Clin Invest 2003; 111:3\u201310.","journal-title":"J Clin Invest"},{"key":"16_CR3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.mrgentox.2008.09.013","volume":"674","author":"L Migliore","year":"2009","unstructured":"Migliore L, Coppede F. Environmental-induced oxidative stress in neurodegenerative disorders and aging. Mutat Res 2009; 674:73\u201384.","journal-title":"Mutat Res"},{"key":"16_CR4","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nature05292","volume":"443","author":"MT Lin","year":"2006","unstructured":"Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006; 443:787\u2013795.","journal-title":"Nature"},{"key":"16_CR5","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bbadis.2009.10.007","volume":"1802","author":"PI Moreira","year":"2010","unstructured":"Moreira PI, Zhu X, Wang X et al. Mitochondria: a therapeutic target in neurodegeneration. Biochim Biophys Acta 2010; 1802:212\u2013220.","journal-title":"Biochim Biophys Acta"},{"key":"16_CR6","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1126\/science.1099320","volume":"305","author":"DR Green","year":"2004","unstructured":"Green DR, Kroemer G. The pathophysiology of mitochondrial cell death. Science 2004; 305:626\u2013629.","journal-title":"Science"},{"key":"16_CR7","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/ana.20624","volume":"58","author":"MF Beal","year":"2005","unstructured":"Beal MF. Mitochondria take center stage in aging and neurodegeneration. Ann Neurol 2005; 58:495\u2013505.","journal-title":"Ann Neurol"},{"key":"16_CR8","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.neuron.2008.10.010","volume":"60","author":"MP Mattson","year":"2008","unstructured":"Mattson MP, Gleichmann M, Cheng A. Mitochondria in neuroplasticity and neurological disorders. Neuron 2008; 60:748\u2013766.","journal-title":"Neuron"},{"key":"16_CR9","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3233\/JAD-2009-0972","volume":"16","author":"PI Moreira","year":"2009","unstructured":"Moreira PI, Duarte AI, Santos MS et al. An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer\u2019s disease. J Alzheimers Dis 2009; 16:741\u2013761.","journal-title":"J Alzheimers Dis"},{"key":"16_CR10","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/00004647-199903000-00001","volume":"19","author":"AN Murphy","year":"1999","unstructured":"Murphy AN, Fiskum G, Beal MF. Mitochondria in neurodegeneration: bioenergetic function in cell life and death. J Cereb Blood Flow Metab 1999; 19:231\u2013245.","journal-title":"J Cereb Blood Flow Metab"},{"key":"16_CR11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10540-007-9038-z","volume":"27","author":"L Petrozzi","year":"2007","unstructured":"Petrozzi L, Ricci G, Giglioli NJ et al. Mitochondria and neurodegeneration. Biosci Rep 2007; 27:87\u2013104.","journal-title":"Biosci Rep"},{"key":"16_CR12","doi-asserted-by":"crossref","unstructured":"Nunomura A, Honda K, Takeda A et al. Oxidative damage to RNA in neurodegenerative diseases. J Biomed Biotechnol 2006:82323.","DOI":"10.1155\/JBB\/2006\/82323"},{"key":"16_CR13","doi-asserted-by":"publisher","first-page":"R169","DOI":"10.1093\/hmg\/ddp326","volume":"18","author":"H Chen","year":"2009","unstructured":"Chen H, Chan DC. Mitochondrial dynamics\u2014fusion, fission, movement and mitophagy\u2014in neurodegenerative diseases. Hum Mol Genet 2009; 18:R169\u2013176.","journal-title":"Hum Mol Genet"},{"key":"16_CR14","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1371\/journal.pone.0003257","volume":"3","author":"PA Parone","year":"2008","unstructured":"Parone PA, Da Cruz S, Tondera D et al. Preventing mitochondrial fission impairs mitochondrial function and leads to loss of mitochondrial DNA. PLoS One 2008; 3:e3257.","journal-title":"PLoS One"},{"key":"16_CR15","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1093\/embo-reports\/kvf113","volume":"3","author":"B Westermann","year":"2002","unstructured":"Westermann B. Merging mitochondria matters: cellular role and molecular machinery of mitochondrial fusion. EMBO Rep 2002; 3:527\u2013531.","journal-title":"EMBO Rep"},{"key":"16_CR16","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1101\/gad.1658508","volume":"22","author":"DF Suen","year":"2008","unstructured":"Suen DF, Norris KL, Youle RJ. Mitochondrial dynamics and apoptosis. Genes Dev 2008; 22:1577\u20131590.","journal-title":"Genes Dev"},{"key":"16_CR17","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.cell.2004.11.003","volume":"119","author":"Z Li","year":"2004","unstructured":"Li Z, Okamoto K, Hayashi Y et al. The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 2004; 119:873\u2013887.","journal-title":"Cell"},{"key":"16_CR18","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.cell.2007.06.026","volume":"130","author":"H Chen","year":"2007","unstructured":"Chen H, McCaffery JM, Chan DC. Mitochondrial fusion protects against neurodegeneration in the cerebellum. Cell 2007; 130:548\u2013562.","journal-title":"Cell"},{"key":"16_CR19","doi-asserted-by":"publisher","first-page":"1000097","DOI":"10.1371\/journal.pgen.1000097","volume":"4","author":"QA Liu","year":"2008","unstructured":"Liu QA, Shio H. Mitochondrial morphogenesis, dendrite development and synapse formation in cerebellum require both Bcl-w and the glutamate receptor delta2. PLoS Genet 2008; 4:e1000097.","journal-title":"PLoS Genet"},{"key":"16_CR20","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/S0896-6273(02)01094-2","volume":"36","author":"RS Stowers","year":"2002","unstructured":"Stowers RS, Megeath LJ, Gorska-Andrzejak J et al. Axonal transport of mitochondria to synapses depends on milton, a novel Drosophila protein. Neuron 2002; 36:1063\u20131077.","journal-title":"Neuron"},{"key":"16_CR21","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.neuron.2005.06.018","volume":"47","author":"P Verstreken","year":"2005","unstructured":"Verstreken P, Ly CV, Venken KJ et al. Synaptic mitochondria are critical for mobilization of reserve pool vesicles at Drosophila neuromuscular junctions. Neuron 2005; 47:365\u2013378.","journal-title":"Neuron"},{"key":"16_CR22","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1056\/NEJMra0909142","volume":"362","author":"HW Querfurth","year":"2010","unstructured":"Querfurth HW, LaFerla FM. Alzheimer\u2019s disease. N Engl J Med 2010; 362:329\u2013344.","journal-title":"N Engl J Med"},{"key":"16_CR23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-2001-3111","volume":"3","author":"DJ Selkoe","year":"2001","unstructured":"Selkoe DJ. Alzheimer\u2019s disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J Alzheimers Dis 2001; 3:75\u201380.","journal-title":"J Alzheimers Dis"},{"key":"16_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1212\/01.wnl.0000192307.15103.83","volume":"66","author":"PI Moreira","year":"2006","unstructured":"Moreira PI, Honda K, Zhu X et al. Brain and brawn: parallels in oxidative strength. Neurology 2006; 66:S97\u2013101.","journal-title":"Neurology"},{"key":"16_CR25","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1089\/ars.2007.1703","volume":"9","author":"PI Moreira","year":"2007","unstructured":"Moreira PI, Santos MS, Oliveira CR. Alzheimer\u2019s disease: a lesson from mitochondrial dysfunction. Antioxid Redox Signal 2007; 9:1621\u20131630.","journal-title":"Antioxid Redox Signal"},{"key":"16_CR26","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.mehy.2003.12.045","volume":"63","author":"RH Swerdlow","year":"2004","unstructured":"Swerdlow RH, Khan SM. A \u201cmitochondrial cascade hypothesis\u201d for sporadic Alzheimer\u2019s disease. Med Hypotheses 2004; 63:8\u201320.","journal-title":"Med Hypotheses"},{"key":"16_CR27","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.expneurol.2009.01.011","volume":"218","author":"RH Swerdlow","year":"2009","unstructured":"Swerdlow RH, Khan SM. The Alzheimer\u2019s disease mitochondrial cascade hypothesis: an update. Exp Neurol 2009; 218:308\u2013315.","journal-title":"Exp Neurol"},{"key":"16_CR28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1385\/JMN:11:2:151","volume":"11","author":"MY Aksenov","year":"1998","unstructured":"Aksenov MY, Tucker HM, Nair P et al. The expression of key oxidative stress-handling genes in different brain regions in Alzheimer\u2019s disease. J Mol Neurosci 1998; 11:151\u2013164.","journal-title":"J Mol Neurosci"},{"key":"16_CR29","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/BF03033159","volume":"5","author":"G Aliev","year":"2003","unstructured":"Aliev G, Smith MA, Obrenovich ME et al. Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Azheimer disease. Neurotox Res 2003; 5:491\u2013504.","journal-title":"Neurotox Res"},{"key":"16_CR30","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1523\/JNEUROSCI.21-09-03017.2001","volume":"21","author":"K Hirai","year":"2001","unstructured":"Hirai K, Aliev G, Nunomura A et al. Mitochondrial abnormalities in Alzheimer\u2019s disease. J Neurosci 2001; 21:3017\u20133023.","journal-title":"J Neurosci"},{"key":"16_CR31","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","volume":"291","author":"GL Anderson","year":"2004","unstructured":"Anderson GL, Limacher M, Assaf AR et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women\u2019s Health Initiative randomized controlled trial. JAMA 2004; 291:1701\u20131712.","journal-title":"JAMA"},{"key":"16_CR32","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/jcbfm.1993.58","volume":"13","author":"NP Azari","year":"1993","unstructured":"Azari NP, Pettigrew KD, Schapiro MB et al. Early detection of Alzheimer\u2019s disease: a statistical approach using positron emission tomographic data. J Cereb Blood Flow Metab 1993; 13:438\u2013447.","journal-title":"J Cereb Blood Flow Metab"},{"key":"16_CR33","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/j.1749-6632.1996.tb32600.x","volume":"802","author":"GW Small","year":"1996","unstructured":"Small GW, Komo S, La Rue A et al. Early detection of Alzheimer\u2019s disease by combining apolipoprotein E and neuroimaging. Ann N Y Acad Sci 1996; 802:70\u201378.","journal-title":"Ann N Y Acad Sci"},{"key":"16_CR34","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1001\/jama.286.17.2120","volume":"286","author":"DH Silverman","year":"2001","unstructured":"Silverman DH, Small GW, Chang CY et al. Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA 2001; 286:2120\u20132127.","journal-title":"JAMA"},{"key":"16_CR35","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/BF01258634","volume":"75","author":"S Hoyer","year":"1989","unstructured":"Hoyer S, Nitsch R. Cerebral excess release of neurotransmitter amino acids subsequent to reduced cerebral glucose metabolism in early-onset dementia of Alzheimer type. J Neural Transm 1989; 75:227\u2013232.","journal-title":"J Neural Transm"},{"key":"16_CR36","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/jnr.10756","volume":"74","author":"HM Huang","year":"2003","unstructured":"Huang HM, Ou HC, Xu H et al. Inhibition of alpha-ketoglutarate dehydrogenase complex promotes cytochrome c release from mitochondria, caspase-3 activation and necrotic cell death. J Neurosci Res 2003; 74:309\u2013317.","journal-title":"J Neurosci Res"},{"key":"16_CR37","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/ana.20474","volume":"57","author":"P Bubber","year":"2005","unstructured":"Bubber P, Haroutunian V, Fisch G et al. Mitochondrial abnormalities in Alzheimer brain: mechanistic implications. Ann Neurol 2005; 57:695\u2013703.","journal-title":"Ann Neurol"},{"key":"16_CR38","doi-asserted-by":"crossref","first-page":"8972","DOI":"10.1523\/JNEUROSCI.20-24-08972.2000","volume":"20","author":"L Tretter","year":"2000","unstructured":"Tretter L, Adam-Vizi V. Inhibition of Krebs cycle enzymes by hydrogen peroxide: A key role of [alpha]-ketoglutarate dehydrogenase in limiting NADH production under oxidative stress. J Neurosci 2000; 20:8972\u20138979.","journal-title":"J Neurosci"},{"key":"16_CR39","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/j.1471-4159.1992.tb09439.x","volume":"59","author":"SJ Kish","year":"1992","unstructured":"Kish SJ, Bergeron C, Rajput A et al. Brain cytochrome oxidase in Alzheimer\u2019s disease. J Neurochem 1992; 59:776\u2013779.","journal-title":"J Neurochem"},{"key":"16_CR40","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1212\/WNL.44.6.1086","volume":"44","author":"WD Parker Jr.","year":"1994","unstructured":"Parker WD, Jr., Mahr NJ, Filley CM et al. Reduced platelet cytochrome c oxidase activity in Alzheimer\u2019s disease. Neurology 1994; 44:1086\u20131090.","journal-title":"Neurology"},{"key":"16_CR41","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0197-4580(01)00314-1","volume":"23","author":"F Bosetti","year":"2002","unstructured":"Bosetti F, Brizzi F, Barogi S et al. Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer\u2019s disease. Neurobiol Aging 2002; 23:371\u2013376.","journal-title":"Neurobiol Aging"},{"key":"16_CR42","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.mito.2006.10.004","volume":"6","author":"J Valla","year":"2006","unstructured":"Valla J, Schneider L, Niedzielko T et al. Impaired platelet mitochondrial activity in Alzheimer\u2019s disease and mild cognitive impairment. Mitochondrion 2006; 6:323\u2013330.","journal-title":"Mitochondrion"},{"key":"16_CR43","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1097\/00001756-199806010-00015","volume":"9","author":"C Pereira","year":"1998","unstructured":"Pereira C, Santos MS, Oliveira C. Mitochondrial function impairment induced by amyloid beta-peptide on PC12 cells. Neuroreport 1998; 9:1749\u20131755.","journal-title":"Neuroreport"},{"key":"16_CR44","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1089\/rej.2009.0937","volume":"13","author":"P Fattoretti","year":"2010","unstructured":"Fattoretti P, Balietti M, Casoli T et al. Decreased numeric density of succinic dehydrogenase-positive mitochondria in CA1 pyramidal neurons of 3xTg-AD mice. Rejuvenation Res 2010; 13:144\u2013147.","journal-title":"Rejuvenation Res"},{"key":"16_CR45","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3233\/JAD-2007-12210","volume":"12","author":"PI Moreira","year":"2007","unstructured":"Moreira PI, Harris PL, Zhu X et al. Lipoic acid and N-acetyl cysteine decrease mitochondrial-related oxidative stress in Alzheimer disease patient fibroblasts. J Alzheimers Dis 2007; 12:195\u2013206.","journal-title":"J Alzheimers Dis"},{"key":"16_CR46","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3233\/JAD-2006-9209","volume":"9","author":"SM Monte de la","year":"2006","unstructured":"de la Monte SM, Wands JR. Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer\u2019s disease. J Alzheimers Dis 2006; 9:167\u2013181.","journal-title":"J Alzheimers Dis"},{"key":"16_CR47","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0891-5849(01)00570-6","volume":"31","author":"RJ Castellani","year":"2001","unstructured":"Castellani RJ, Harris PL, Sayre LM et al. Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine. Free Radic Biol Med 2001; 31:175\u2013180.","journal-title":"Free Radic Biol Med"},{"key":"16_CR48","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1523\/JNEUROSCI.19-06-01959.1999","volume":"19","author":"A Nunomura","year":"1999","unstructured":"Nunomura A, Perry G, Pappolla MA et al. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer\u2019s disease. J Neurosci 1999; 19:1959\u20131964.","journal-title":"J Neurosci"},{"key":"16_CR49","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/jnen\/60.8.759","volume":"60","author":"A Nunomura","year":"2001","unstructured":"Nunomura A, Perry G, Aliev G et al. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 2001; 60:759\u2013767.","journal-title":"J Neuropathol Exp Neurol"},{"key":"16_CR50","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1523\/JNEUROSCI.17-08-02653.1997","volume":"17","author":"MA Smith","year":"1997","unstructured":"Smith MA, Richey Harris PL, Sayre LM et al. Widespread peroxynitrite-mediated damage in Alzheimer\u2019s disease. J Neurosci 1997; 17:2653\u20132657.","journal-title":"J Neurosci"},{"key":"16_CR51","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1016\/j.febslet.2005.03.094","volume":"579","author":"E Straface","year":"2005","unstructured":"Straface E, Matarrese P, Gambardella L et al. Oxidative imbalance and cathepsin D changes as peripheral blood biomarkers of Alzheimer disease: a pilot study. FEBS Lett 2005; 579:2759\u20132766.","journal-title":"FEBS Lett"},{"key":"16_CR52","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/elps.200500420","volume":"27","author":"NS Hamblet","year":"2006","unstructured":"Hamblet NS, Ragland B, Ali M et al. Mutations in mitochondrial-encoded cytochrome c oxidase subunits I, II and III genes detected in Alzheimer\u2019s disease using single-strand conformation polymorphism. Electrophoresis 2006; 27:398\u2013408.","journal-title":"Electrophoresis"},{"key":"16_CR53","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0006-8993(00)03190-5","volume":"893","author":"X Qiu","year":"2001","unstructured":"Qiu X, Chen Y, Zhou M. Two point mutations in mitochondrial DNA of cytochrome c oxidase coexist with normal mtDNA in a patient with Alzheimer\u2019s disease. Brain Res 2001; 893:261\u2013263.","journal-title":"Brain Res"},{"key":"16_CR54","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/hmg\/11.2.133","volume":"11","author":"MT Lin","year":"2002","unstructured":"Lin MT, Simon DK, Ahn CH et al. High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer\u2019s disease brain. Hum Mol Genet 2002; 11:133\u2013145.","journal-title":"Hum Mol Genet"},{"key":"16_CR55","doi-asserted-by":"publisher","first-page":"10726","DOI":"10.1073\/pnas.0403649101","volume":"101","author":"PE Coskun","year":"2004","unstructured":"Coskun PE, Beal MF, Wallace DC. Alzheimer\u2019s brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. Proc Natl Acad Sci USA 2004; 101:10726\u201310731.","journal-title":"Proc Natl Acad Sci USA"},{"key":"16_CR56","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s10571-009-9398-y","volume":"29","author":"V Rhein","year":"2009","unstructured":"Rhein V, Baysang G, Rao S et al. Amyloid-beta leads to impaired cellular respiration, energy production and mitochondrial electron chain complex activities in human neuroblastoma cells. Cell Mol Neurobiol 2009; 29:1063\u20131071.","journal-title":"Cell Mol Neurobiol"},{"key":"16_CR57","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1096\/fj.04-2582fje","volume":"19","author":"K Takuma","year":"2005","unstructured":"Takuma K, Yao J, Huang J et al. ABAD enhances Abeta-induced cell stress via mitochondrial dysfunction. FASEB J 2005; 19:597\u2013598.","journal-title":"FASEB J"},{"key":"16_CR58","doi-asserted-by":"publisher","first-page":"13576","DOI":"10.1073\/pnas.0902714106","volume":"106","author":"CA Massaad","year":"2009","unstructured":"Massaad CA, Washington TM, Pautler RG et al. Overexpression of SOD-2 reduces hippocampal superoxide and prevents memory deficits in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci USA 2009; 106:13576\u201313581.","journal-title":"Proc Natl Acad Sci USA"},{"key":"16_CR59","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.2353\/ajpath.2006.051223","volume":"168","author":"M Anantharaman","year":"2006","unstructured":"Anantharaman M, Tangpong J, Keller JN et al. Beta-amyloid mediated nitration of manganese superoxide dismutase: implication for oxidative stress in a APPNLH\/NLH X PS-1P264L\/P264L double knock-in mouse model of Alzheimer\u2019s disease. Am J Pathol 2006; 168:1608\u20131618.","journal-title":"Am J Pathol"},{"key":"16_CR60","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1371\/journal.pone.0000536","volume":"2","author":"S Melov","year":"2007","unstructured":"Melov S, Adlard PA, Morten K et al. Mitochondrial oxidative stress causes hyperphosphorylation of tau. PLoS ONE 2007; 2:e536.","journal-title":"PLoS ONE"},{"key":"16_CR61","doi-asserted-by":"publisher","first-page":"5167","DOI":"10.1523\/JNEUROSCI.0482-06.2006","volume":"26","author":"L Esposito","year":"2006","unstructured":"Esposito L, Raber J, Kekonius L et al. Reduction in mitochondrial superoxide dismutase modulates Alzheimer\u2019s disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice. J Neurosci 2006; 26:5167\u20135179.","journal-title":"J Neurosci"},{"key":"16_CR62","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1111\/j.1471-4159.2004.02455.x","volume":"89","author":"F Li","year":"2004","unstructured":"Li F, Calingasan NY, Yu F et al. Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice. J Neurochem 2004; 89:1308\u20131312.","journal-title":"J Neurochem"},{"key":"16_CR63","doi-asserted-by":"publisher","first-page":"10561","DOI":"10.1371\/journal.pone.0010561","volume":"5","author":"CA Massaad","year":"2010","unstructured":"Massaad CA, Amin SK, Hu L et al. Mitochondrial superoxide contributes to blood flow and axonal transport deficits in the Tg2576 mouse model of Alzheimer\u2019s disease. PLoS One 2010; 5:e10561.","journal-title":"PLoS One"},{"key":"16_CR64","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1523\/JNEUROSCI.4276-04.2005","volume":"25","author":"PJ Crouch","year":"2005","unstructured":"Crouch PJ, Blake R, Duce JA et al. Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta1-42. J Neurosci 2005; 25:672\u2013679.","journal-title":"J Neurosci"},{"key":"16_CR65","doi-asserted-by":"publisher","first-page":"28294","DOI":"10.1074\/jbc.M212265200","volume":"278","author":"CA Marques","year":"2003","unstructured":"Marques CA, Keil U, Bonert A et al. Neurotoxic mechanisms caused by the Alzheimer\u2019s disease-linked Swedish amyloid precursor protein mutation: oxidative stress, caspases and the JNK pathway. J Biol Chem 2003; 278:28294\u201328302.","journal-title":"J Biol Chem"},{"key":"16_CR66","doi-asserted-by":"publisher","first-page":"9057","DOI":"10.1523\/JNEUROSCI.1469-06.2006","volume":"26","author":"L Devi","year":"2006","unstructured":"Devi L, Prabhu BM, Galati DF et al. Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer\u2019s disease brain is associated with mitochondrial dysfunction. J Neurosci 2006; 26:9057\u20139068.","journal-title":"J Neurosci"},{"key":"16_CR67","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1083\/jcb.200207030","volume":"161","author":"HK Anandatheerthavarada","year":"2003","unstructured":"Anandatheerthavarada HK, Biswas G, Robin MA et al. Mitochondrial targeting and a novel transmembrane arrest of Alzheimer\u2019s amyloid precursor protein impairs mitochondrial function in neuronal cells. J Cell Biol 2003; 161:41\u201354.","journal-title":"J Cell Biol"},{"key":"16_CR68","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1096\/fj.05-3735fje","volume":"19","author":"C Caspersen","year":"2005","unstructured":"Caspersen C, Wang N, Yao J et al. Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer\u2019s disease. FASEB J 2005; 19:2040\u20132041.","journal-title":"FASEB J"},{"key":"16_CR69","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/hmg\/ddl066","volume":"15","author":"M Manczak","year":"2006","unstructured":"Manczak M, Anekonda TS, Henson E et al. Mitochondria are a direct site of A beta accumulation in Alzheimer\u2019s disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum Mol Genet 2006; 15:1437\u20131449.","journal-title":"Hum Mol Genet"},{"key":"16_CR70","doi-asserted-by":"crossref","unstructured":"Pavlov PF, Wiehager B, Sakai J et al. Mitochondrial gamma-secretase participates in the metabolism of mitochondria-associated amyloid precursor protein. FASEB J 2010","DOI":"10.1096\/fj.10-157230"},{"key":"16_CR71","doi-asserted-by":"publisher","first-page":"8310","DOI":"10.1371\/journal.pone.0008310","volume":"4","author":"K Iijima-Ando","year":"2009","unstructured":"Iijima-Ando K, Hearn SA, Shenton C et al. Mitochondrial mislocalization underlies Abeta42-induced neuronal dysfunction in a Drosophila model of Alzheimer\u2019s disease. PLoS One 2009; 4:e8310.","journal-title":"PLoS One"},{"key":"16_CR72","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.0959-9673.2005.00427.x","volume":"86","author":"SD Yan","year":"2005","unstructured":"Yan SD, Stern DM. Mitochondrial dysfunction and Alzheimer\u2019s disease: role of amyloid-beta peptide alcohol dehydrogenase (ABAD). Int J Exp Pathol 2005; 86:161\u2013171.","journal-title":"Int J Exp Pathol"},{"key":"16_CR73","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1126\/science.1091230","volume":"304","author":"JW Lustbader","year":"2004","unstructured":"Lustbader JW, Cirilli M, Lin C et al. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer\u2019s disease. Science 2004; 304:448\u2013452.","journal-title":"Science"},{"key":"16_CR74","doi-asserted-by":"publisher","first-page":"13145","DOI":"10.1073\/pnas.0806192105","volume":"105","author":"CA Hansson Petersen","year":"2008","unstructured":"Hansson Petersen CA, Alikhani N, Behbahani H et al. The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae. Proc Natl Acad Sci USA 2008; 105:13145\u201313150.","journal-title":"Proc Natl Acad Sci USA"},{"key":"16_CR75","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1023\/A:1015536808304","volume":"21","author":"PI Moreira","year":"2001","unstructured":"Moreira PI, Santos MS, Moreno A et al. Amyloid beta-peptide promotes permeability transition pore in brain mitochondria. Biosci Rep 2001; 21:789\u2013800.","journal-title":"Biosci Rep"},{"key":"16_CR76","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/jnr.10282","volume":"69","author":"PI Moreira","year":"2002","unstructured":"Moreira PI, Santos MS, Moreno A et al. Effect of amyloid beta-peptide on permeability transition pore: a comparative study. J Neurosci Res 2002; 69:257\u2013267.","journal-title":"J Neurosci Res"},{"key":"16_CR77","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/nm.1868","volume":"14","author":"H Du","year":"2008","unstructured":"Du H, Guo L, Fang F et al. Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer\u2019s disease. Nat Med 2008; 14:1097\u20131105.","journal-title":"Nat Med"},{"key":"16_CR78","doi-asserted-by":"publisher","first-page":"29096","DOI":"10.1074\/jbc.M602532200","volume":"281","author":"A Falkevall","year":"2006","unstructured":"Falkevall A, Alikhani N, Bhushan S et al. Degradation of the amyloid beta-protein by the novel mitochondrial peptidasome, PreP. J Biol Chem 2006; 281:29096\u201329104.","journal-title":"J Biol Chem"},{"key":"16_CR79","doi-asserted-by":"crossref","first-page":"20057","DOI":"10.1073\/pnas.0905529106","volume":"106","author":"V Rhein","year":"2009","unstructured":"Rhein V, Song X, Wiesner A et al. Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer\u2019s disease mice. Proc Natl Acad Sci USA 2009; 106:20057\u201320062.","journal-title":"Proc Natl Acad Sci USA"},{"key":"16_CR80","doi-asserted-by":"publisher","first-page":"23802","DOI":"10.1074\/jbc.M500356200","volume":"280","author":"DC David","year":"2005","unstructured":"David DC, Hauptmann S, Scherping I et al. Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice. J Biol Chem 2005; 280:23802\u201323814.","journal-title":"J Biol Chem"},{"key":"16_CR81","doi-asserted-by":"publisher","first-page":"5699","DOI":"10.1046\/j.1432-1327.2000.01589.x","volume":"267","author":"CW Gray","year":"2000","unstructured":"Gray CW, Ward RV, Karran E et al. Characterization of human HtrA2, a novel serine protease involved in the mammalian cellular stress response. Eur J Biochem 2000; 267:5699\u20135710.","journal-title":"Eur J Biochem"},{"key":"16_CR82","doi-asserted-by":"publisher","first-page":"45844","DOI":"10.1074\/jbc.M404940200","volume":"279","author":"S Gupta","year":"2004","unstructured":"Gupta S, Singh R, Datta P et al. The C-terminal tail of presenilin regulates Omi\/HtrA2 protease activity. J Biol Chem 2004; 279:45844\u201345854.","journal-title":"J Biol Chem"},{"key":"16_CR83","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neulet.2003.11.068","volume":"357","author":"HJ Park","year":"2004","unstructured":"Park HJ, Seong YM, Choi JY et al. Alzheimer\u2019s disease-associated amyloid beta interacts with the human serine protease HtrA2\/Omi. Neurosci Lett 2004; 357:63\u201367.","journal-title":"Neurosci Lett"},{"key":"16_CR84","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3233\/JAD-2009-1037","volume":"17","author":"J Kooistra","year":"2009","unstructured":"Kooistra J, Milojevic J, Melacini G et al. A new function of human HtrA2 as an amyloid-beta oligomerization inhibitor. J Alzheimers Dis 2009; 17:281\u2013294.","journal-title":"J Alzheimers Dis"},{"key":"16_CR85","doi-asserted-by":"publisher","first-page":"34277","DOI":"10.1074\/jbc.M603443200","volume":"281","author":"HJ Park","year":"2006","unstructured":"Park HJ, Kim SS, Seong YM et al. Beta-amyloid precursor protein is a direct cleavage target of HtrA2 serine protease. Implications for the physiological function of HtrA2 in the mitochondria. J Biol Chem 2006; 281:34277\u201334287.","journal-title":"J Biol Chem"},{"key":"16_CR86","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.neuint.2010.08.004","volume":"57","author":"H Behbahani","year":"2010","unstructured":"Behbahani H, Pavlov PF, Wiehager B et al. Association of Omi\/HtrA2 with gamma-secretase in mitochondria. Neurochem Int 2010; 57:668\u2013675.","journal-title":"Neurochem Int"},{"key":"16_CR87","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3233\/JAD-2006-9204","volume":"9","author":"SJ Baloyannis","year":"2006","unstructured":"Baloyannis SJ. Mitochondrial alterations in Alzheimer\u2019s disease. J Alzheimers Dis 2006; 9:119\u2013126.","journal-title":"J Alzheimers Dis"},{"key":"16_CR88","doi-asserted-by":"crossref","first-page":"614","DOI":"10.4161\/auto.4872","volume":"3","author":"PI Moreira","year":"2007","unstructured":"Moreira PI, Siedlak SL, Wang X et al. Increased autophagic degradation of mitochondria in Alzheimer disease. Autophagy 2007; 3:614\u2013615.","journal-title":"Autophagy"},{"key":"16_CR89","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/01.jnen.0000240476.73532.b0","volume":"66","author":"PI Moreira","year":"2007","unstructured":"Moreira PI, Siedlak SL, Wang X et al. Autophagocytosis of mitochondria is prominent in Alzheimer disease. J Neuropathol Exp Neurol 2007; 66:525\u2013532.","journal-title":"J Neuropathol Exp Neurol"},{"key":"16_CR90","doi-asserted-by":"publisher","first-page":"470","DOI":"10.2353\/ajpath.2008.071208","volume":"173","author":"X Wang","year":"2008","unstructured":"Wang X, Su B, Fujioka H et al. Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer\u2019s disease patients. Am J Pathol 2008; 173:470\u2013482.","journal-title":"Am J Pathol"},{"issue":"Suppl 1","key":"16_CR91","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1471-4159.2009.05867.x","volume":"109","author":"X Wang","year":"2009","unstructured":"Wang X, Su B, Zheng L et al. The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer\u2019s disease. J Neurochem 2009; 109 Suppl 1:153\u2013159.","journal-title":"J Neurochem"},{"key":"16_CR92","doi-asserted-by":"publisher","first-page":"19318","DOI":"10.1073\/pnas.0804871105","volume":"105","author":"X Wang","year":"2008","unstructured":"Wang X, Su B, Siedlak SL et al. Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission\/fusion proteins. Proc Natl Acad Sci USA 2008; 105:19318\u201319323.","journal-title":"Proc Natl Acad Sci USA"},{"key":"16_CR93","doi-asserted-by":"publisher","first-page":"9090","DOI":"10.1523\/JNEUROSCI.1357-09.2009","volume":"29","author":"X Wang","year":"2009","unstructured":"Wang X, Su B, Lee HG et al. Impaired balance of mitochondrial fission and fusion in Alzheimer\u2019s disease. J Neurosci 2009; 29:9090\u20139103.","journal-title":"J Neurosci"},{"key":"16_CR94","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1749-6632.1993.tb23028.x","volume":"695","author":"H Lassmann","year":"1993","unstructured":"Lassmann H, Fischer P, Jellinger K. Synaptic pathology of Alzheimer\u2019s disease. Ann N Y Acad Sci 1993; 695:59\u201364.","journal-title":"Ann N Y Acad Sci"},{"key":"16_CR95","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/BF01273157","volume":"103","author":"K Blennow","year":"1996","unstructured":"Blennow K, Bogdanovic N, Alafuzoff I et al. Synaptic pathology in Alzheimer\u2019s disease: relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele. J Neural Transm 1996; 103:603\u2013618.","journal-title":"J Neural Transm"},{"key":"16_CR96","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1126\/science.1105681","volume":"307","author":"GB Stokin","year":"2005","unstructured":"Stokin GB, Lillo C, Falzone TL et al. Axonopathy and transport deficits early in the pathogenesis of Alzheimer\u2019s disease. Science 2005; 307:1282\u20131288.","journal-title":"Science"},{"key":"16_CR97","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/nm1782","volume":"14","author":"GM Shankar","year":"2008","unstructured":"Shankar GM, Li S, Mehta TH et al. Amyloid-beta protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory. Nat Med 2008; 14:837\u2013842.","journal-title":"Nat Med"},{"key":"16_CR98","doi-asserted-by":"publisher","first-page":"10480","DOI":"10.1523\/JNEUROSCI.3231-06.2006","volume":"26","author":"Y Rui","year":"2006","unstructured":"Rui Y, Tiwari P, Xie Z et al. Acute impairment of mitochondrial trafficking by beta-amyloid peptides in hippocampal neurons. J Neurosci 2006; 26:10480\u201310487.","journal-title":"J Neurosci"},{"key":"16_CR99","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1159\/000283484","volume":"7","author":"X Wang","year":"2010","unstructured":"Wang X, Perry G, Smith MA et al. Amyloid-beta-derived diffusible ligands cause impaired axonal transport of mitochondria in neurons. Neurodegener Dis 2010; 7:56\u201359.","journal-title":"Neurodegener Dis"},{"key":"16_CR100","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1756-6606-3-10","volume":"3","author":"Y Rui","year":"2010","unstructured":"Rui Y, Gu J, Yu K et al. Inhibition of AMPA receptor trafficking at hippocampal synapses by beta-amyloid oligomers: the mitochondrial contribution. Mol Brain 2010; 3:10.","journal-title":"Mol Brain"},{"key":"16_CR101","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1212\/WNL.48.5.1277","volume":"48","author":"MC Rijk de","year":"1997","unstructured":"de Rijk MC, Rocca WA, Anderson DW et al. A population perspective on diagnostic criteria for Parkinson\u2019s disease. Neurology 1997; 48:1277\u20131281.","journal-title":"Neurology"},{"key":"16_CR102","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1212\/01.WNL.0000140706.52798.BE","volume":"63","author":"LM Lau de","year":"2004","unstructured":"de Lau LM, Giesbergen PC, de Rijk MC et al. Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study. Neurology 2004; 63:1240\u20131244.","journal-title":"Neurology"},{"key":"16_CR103","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2174\/1568007054546072","volume":"4","author":"SM Cardoso","year":"2005","unstructured":"Cardoso SM, Moreira PI, Agostinho P et al. Neurodegenerative pathways in Parkinson\u2019s disease: therapeutic strategies. Curr Drug Targets CNS Neurol Disord 2005; 4:405\u2013419.","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"16_CR104","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.expneurol.2009.03.006","volume":"218","author":"H Bueler","year":"2009","unstructured":"Bueler H. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson\u2019s disease. Exp Neurol 2009; 218:235\u2013246.","journal-title":"Exp Neurol"},{"key":"16_CR105","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/ana.21022","volume":"60","author":"J Hardy","year":"2006","unstructured":"Hardy J, Cai H, Cookson MR et al. Genetics of Parkinson\u2019s disease and parkinsonism. Ann Neurol 2006; 60:389\u2013398.","journal-title":"Ann Neurol"},{"key":"16_CR106","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.bbadis.2008.11.007","volume":"1792","author":"R Banerjee","year":"2009","unstructured":"Banerjee R, Starkov AA, Beal MF et al. Mitochondrial dysfunction in the limelight of Parkinson\u2019s disease pathogenesis. Biochim Biophys Acta 2009; 1792:651\u2013663.","journal-title":"Biochim Biophys Acta"},{"key":"16_CR107","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S1474-4422(07)70327-7","volume":"7","author":"AH Schapira","year":"2008","unstructured":"Schapira AH. Mitochondria in the aetiology and pathogenesis of Parkinson\u2019s disease. Lancet Neurol 2008; 7:97\u2013109.","journal-title":"Lancet Neurol"},{"key":"16_CR108","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","volume":"54","author":"AH Schapira","year":"1990","unstructured":"Schapira AH, Cooper JM, Dexter D et al. Mitochondrial complex I deficiency in Parkinson\u2019s disease. J Neurochem 1990; 54:823\u2013827.","journal-title":"J Neurochem"},{"key":"16_CR109","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1002\/ana.410360612","volume":"36","author":"VM Mann","year":"1994","unstructured":"Mann VM, Cooper JM, Daniel SE et al. Complex I, iron and ferritin in Parkinson\u2019s disease substantia nigra. Ann Neurol 1994; 36:876\u2013881.","journal-title":"Ann Neurol"},{"key":"16_CR110","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/ana.410260606","volume":"26","author":"WD Parker Jr.","year":"1989","unstructured":"Parker WD, Jr., Boyson SJ, Parks JK. Abnormalities of the electron transport chain in idiopathic Parkinson\u2019s disease. Ann Neurol 1989; 26:719\u2013723.","journal-title":"Ann Neurol"},{"key":"16_CR111","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1002\/ana.410320612","volume":"32","author":"D Krige","year":"1992","unstructured":"Krige D, Carroll MT, Cooper JM et al. Platelet mitochondrial function in Parkinson\u2019s disease. The Royal Kings and Queens Parkinson Disease Research Group. Ann Neurol 1992; 32:782\u2013788.","journal-title":"Ann Neurol"},{"key":"16_CR112","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/ana.410370604","volume":"37","author":"RH Haas","year":"1995","unstructured":"Haas RH, Nasirian F, Nakano K et al. Low platelet mitochondrial complex I and complex II\/III activity in early untreated Parkinson\u2019s disease. Ann Neurol 1995; 37:714\u2013722.","journal-title":"Ann Neurol"},{"key":"16_CR113","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/mds.870130106","volume":"13","author":"F Blandini","year":"1998","unstructured":"Blandini F, Nappi G, Greenamyre JT. Quantitative study of mitochondrial complex I in platelets of parkinsonian patients. Mov Disord 1998; 13:11\u201315.","journal-title":"Mov Disord"},{"key":"16_CR114","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/clinchem\/39.4.667","volume":"39","author":"N Barroso","year":"1993","unstructured":"Barroso N, Campos Y, Huertas R et al. Respiratory chain enzyme activities in lymphocytes from untreated patients with Parkinson disease. Clin Chem 1993; 39:667\u2013669.","journal-title":"Clin Chem"},{"key":"16_CR115","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/BF02257619","volume":"4","author":"H Yoshino","year":"1992","unstructured":"Yoshino H, Nakagawa-Hattori Y, Kondo T et al. Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson\u2019s disease. J Neural Transm Park Dis Dement Sect 1992; 4:27\u201334.","journal-title":"J Neural Transm Park Dis Dement Sect"},{"key":"16_CR116","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0022-510X(94)90245-3","volume":"125","author":"DJ Taylor","year":"1994","unstructured":"Taylor DJ, Krige D, Barnes PR et al. A 31P magnetic resonance spectroscopy study of mitochondrial function in skeletal muscle of patients with Parkinson\u2019s disease. J Neurol Sci 1994; 125:77\u201381.","journal-title":"J Neurol Sci"},{"key":"16_CR117","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1212\/WNL.45.11.2097","volume":"45","author":"AM Penn","year":"1995","unstructured":"Penn AM, Roberts T, Hodder J et al. Generalized mitochondrial dysfunction in Parkinson\u2019s disease detected by magnetic resonance spectroscopy of muscle. Neurology 1995; 45:2097\u20132099.","journal-title":"Neurology"},{"key":"16_CR118","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.brainres.2007.10.061","volume":"1189","author":"WD Parker Jr.","year":"2008","unstructured":"Parker WD, Jr., Parks JK, Swerdlow RH. Complex I deficiency in Parkinson\u2019s disease frontal cortex. Brain Res 2008; 1189:215\u2013218.","journal-title":"Brain Res"},{"key":"16_CR119","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.bbagen.2008.02.005","volume":"1780","author":"SJ Chinta","year":"2008","unstructured":"Chinta SJ, Andersen JK. Redox imbalance in Parkinson\u2019s disease. Biochim Biophys Acta 2008; 1780:1362\u20131367.","journal-title":"Biochim Biophys Acta"},{"key":"16_CR120","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/1097-4547(20000915)61:6<693::AID-JNR13>3.0.CO;2-4","volume":"61","author":"GA Veech","year":"2000","unstructured":"Veech GA, Dennis J, Keeney PM et al. Disrupted mitochondrial electron transport function increases expression of anti-apoptotic bcl-2 and bcl-X(L) proteins in SH-SY5Y neuroblastoma and in Parkinson disease cybrid cells through oxidative stress. J Neurosci Res 2000; 61:693\u2013700.","journal-title":"J Neurosci Res"},{"key":"16_CR121","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1046\/j.1471-4159.2003.02168.x","volume":"88","author":"PA Trimmer","year":"2004","unstructured":"Trimmer PA, Borland MK, Keeney PM et al. Parkinson\u2019s disease transgenic mitochondrial cybrids generate Lewy inclusion bodies. J Neurochem 2004; 88:800\u2013812.","journal-title":"J Neurochem"},{"key":"16_CR122","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/81834","volume":"3","author":"R Betarbet","year":"2000","unstructured":"Betarbet R, Sherer TB, MacKenzie G et al. Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease. Nat Neurosci 2000; 3:1301\u20131306.","journal-title":"Nat Neurosci"},{"key":"16_CR123","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/ana.21288","volume":"63","author":"DM Gash","year":"2008","unstructured":"Gash DM, Rutland K, Hudson NL et al. Trichloroethylene: Parkinsonism and complex 1 mitochondrial neurotoxicity. Ann Neurol 2008; 63:184\u2013192.","journal-title":"Ann Neurol"},{"key":"16_CR124","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/j.1471-4159.2006.04333.x","volume":"100","author":"TB Sherer","year":"2007","unstructured":"Sherer TB, Richardson JR, Testa CM et al. Mechanism of toxicity of pesticides acting at complex I: relevance to environmental etiologies of Parkinson\u2019s disease. J Neurochem 2007; 100:1469\u20131479.","journal-title":"J Neurochem"},{"key":"16_CR125","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1074\/mcp.M500382-MCP200","volume":"5","author":"J Jin","year":"2006","unstructured":"Jin J, Hulette C, Wang Y et al. Proteomic identification of a stress protein, mortalin\/mthsp70\/GRP75: relevance to Parkinson disease. Mol Cell Proteomics 2006; 5:1193\u20131204.","journal-title":"Mol Cell Proteomics"},{"key":"16_CR126","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1016\/j.febslet.2010.03.012","volume":"584","author":"K Banerjee","year":"2010","unstructured":"Banerjee K, Sinha M, Pham Cle L et al. Alpha-synuclein induced membrane depolarization and loss of phosphorylation capacity of isolated rat brain mitochondria: implications in Parkinson\u2019s disease. FEBS Lett 2010; 584:1571\u20131576.","journal-title":"FEBS Lett"},{"issue":"Spec 2","key":"16_CR127","doi-asserted-by":"publisher","first-page":"R183","DOI":"10.1093\/hmg\/ddm159","volume":"16","author":"B Thomas","year":"2007","unstructured":"Thomas B, Beal MF. Parkinson\u2019s disease. Hum Mol Genet 2007; 16 Spec No. 2:R183\u2013194.","journal-title":"Hum Mol Genet"},{"key":"16_CR128","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/ana.20417","volume":"57","author":"A Pyle","year":"2005","unstructured":"Pyle A, Foltynie T, Tiangyou W et al. Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD. Ann Neurol 2005; 57:564\u2013567.","journal-title":"Ann Neurol"},{"key":"16_CR129","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/ana.410440605","volume":"44","author":"RH Swerdlow","year":"1998","unstructured":"Swerdlow RH, Parks JK, Davis JN, 2nd et al. Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson\u2019s disease family. Ann Neurol 1998; 44:873\u2013881.","journal-title":"Ann Neurol"},{"key":"16_CR130","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/ng1778","volume":"38","author":"Y Kraytsberg","year":"2006","unstructured":"Kraytsberg Y, Kudryavtseva E, McKee AC et al. Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat Genet 2006; 38:518\u2013520.","journal-title":"Nat Genet"},{"key":"16_CR131","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1073\/pnas.0605208103","volume":"104","author":"MI Ekstrand","year":"2007","unstructured":"Ekstrand MI, Terzioglu M, Galter D et al. Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons. Proc Natl Acad Sci USA 2007; 104:1325\u20131330.","journal-title":"Proc Natl Acad Sci USA"},{"key":"16_CR132","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/nrn2417","volume":"9","author":"AB Knott","year":"2008","unstructured":"Knott AB, Perkins G, Schwarzenbacher R et al. Mitochondrial fragmentation in neurodegeneration. Nat Rev Neurosci 2008; 9:505\u2013518.","journal-title":"Nat Rev Neurosci"},{"key":"16_CR133","doi-asserted-by":"publisher","first-page":"4597","DOI":"10.1371\/journal.pone.0004597","volume":"4","author":"W Liu","year":"2009","unstructured":"Liu W, Vives-Bauza C, Acin-Perez R et al. PINK1 defect causes mitochondrial dysfunction, proteasomal deficit and alpha-synuclein aggregation in cell culture models of Parkinson\u2019s disease. PLoS ONE 2009; 4:e4597.","journal-title":"PLoS ONE"},{"key":"16_CR134","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/cdd.2008.166","volume":"16","author":"N Moisoi","year":"2009","unstructured":"Moisoi N, Klupsch K, Fedele V et al. Mitochondrial dysfunction triggered by loss of HtrA2 results in the activation of a brain-specific transcriptional stress response. Cell Death Differ 2009; 16:449\u2013464.","journal-title":"Cell Death Differ"},{"key":"16_CR135","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S0014-4886(03)00342-X","volume":"186","author":"DD Song","year":"2004","unstructured":"Song DD, Shults CW, Sisk A et al. Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP. Exp Neurol 2004; 186:158\u2013172.","journal-title":"Exp Neurol"},{"key":"16_CR136","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0002-9440(10)64553-1","volume":"157","author":"LJ Hsu","year":"2000","unstructured":"Hsu LJ, Sagara Y, Arroyo A et al alpha-synuclein promotes mitochondrial deficit and oxidative stress. Am J Pathol 2000; 157:401\u2013410.","journal-title":"Am J Pathol"},{"key":"16_CR137","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.nbd.2005.08.018","volume":"21","author":"P Klivenyi","year":"2006","unstructured":"Klivenyi P, Siwek D, Gardian G et al. Mice lacking alpha-synuclein are resistant to mitochondrial toxins. Neurobiol Dis 2006; 21:541\u2013548.","journal-title":"Neurobiol Dis"},{"key":"16_CR138","doi-asserted-by":"publisher","first-page":"14524","DOI":"10.1073\/pnas.172514599","volume":"99","author":"W Dauer","year":"2002","unstructured":"Dauer W, Kholodilov N, Vila M et al. Resistance of alpha-synuclein null mice to the parkinsonian neurotoxin MPTP. Proc Natl Acad Sci USA 2002; 99:14524\u201314529.","journal-title":"Proc Natl Acad Sci USA"},{"key":"16_CR139","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1073\/pnas.0911187107","volume":"107","author":"C Vives-Bauza","year":"2010","unstructured":"Vives-Bauza C, Zhou C, Huang Y et al. PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc Natl Acad Sci USA 2010; 107:378\u2013383.","journal-title":"Proc Natl Acad Sci USA"},{"key":"16_CR140","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.febslet.2010.02.016","volume":"584","author":"S Kawajiri","year":"2010","unstructured":"Kawajiri S, Saiki S, Sato S et al. PINK1 is recruited to mitochondria with parkin and associates with LC3 in mitophagy. FEBS Lett 2010; 584:1073\u20131079.","journal-title":"FEBS Lett"},{"key":"16_CR141","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1083\/jcb.200910140","volume":"189","author":"N Matsuda","year":"2010","unstructured":"Matsuda N, Sato S, Shiba K et al. PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy. J Cell Biol 2010; 189:211\u2013221.","journal-title":"J Cell Biol"},{"key":"16_CR142","doi-asserted-by":"publisher","first-page":"1000298","DOI":"10.1371\/journal.pbio.1000298","volume":"8","author":"DP Narendra","year":"2010","unstructured":"Narendra DP, Jin SM, Tanaka A et al. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol 2010; 8:e1000298.","journal-title":"PLoS Biol"},{"key":"16_CR143","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/ncb2012","volume":"12","author":"S Geisler","year":"2010","unstructured":"Geisler S, Holmstrom KM, Skujat D et al. PINK1\/Parkin-mediated mitophagy is dependent on VDAC1 and p62\/SQSTM1. Nat Cell Biol 2010; 12:119\u2013131.","journal-title":"Nat Cell Biol"},{"key":"16_CR144","doi-asserted-by":"publisher","first-page":"871","DOI":"10.4161\/auto.6.7.13286","volume":"6","author":"S Geisler","year":"2010","unstructured":"Geisler S, Holmstrom KM, Treis A et al. The PINK1\/Parkin-mediated mitophagy is compromised by PD-associated mutations. Autophagy 2010; 6:871\u2013878.","journal-title":"Autophagy"},{"key":"16_CR145","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1073\/pnas.0709336105","volume":"105","author":"AC Poole","year":"2008","unstructured":"Poole AC, Thomas RE, Andrews LA et al. The PINK1\/Parkin pathway regulates mitochondrial morphology. Proc Natl Acad Sci USA 2008; 105:1638\u20131643.","journal-title":"Proc Natl Acad Sci USA"},{"key":"16_CR146","doi-asserted-by":"publisher","first-page":"14503","DOI":"10.1073\/pnas.0803998105","volume":"105","author":"H Deng","year":"2008","unstructured":"Deng H, Dodson MW, Huang H et al. The Parkinson\u2019s disease genes pink1 and parkin promote mitochondrial fission and\/or inhibit fusion in Drosophila. Proc Natl Acad Sci USA 2008; 105:14503\u201314508.","journal-title":"Proc Natl Acad Sci USA"},{"key":"16_CR147","doi-asserted-by":"publisher","first-page":"22938","DOI":"10.1074\/jbc.M109.035774","volume":"284","author":"AK Lutz","year":"2009","unstructured":"Lutz AK, Exner N, Fett ME et al. Loss of parkin or PINK1 function increases Drp1-dependent mitochondrial fragmentation. J Biol Chem 2009; 284:22938\u201322951.","journal-title":"J Biol Chem"},{"key":"16_CR148","doi-asserted-by":"publisher","first-page":"11740","DOI":"10.1074\/jbc.M109.066662","volume":"285","author":"M Cui","year":"2010","unstructured":"Cui M, Tang X, Christian WV et al. Perturbations in mitochondrial dynamics induced by human mutant PINK1 can be rescued by the mitochondrial division inhibitor mdivi-1. J Biol Chem 2010; 285:11740\u201311752.","journal-title":"J Biol Chem"},{"key":"16_CR149","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/nrg1686","volume":"6","author":"GP Bates","year":"2005","unstructured":"Bates GP. History of genetic disease: the molecular genetics of Huntington disease\u2014a history. Nat Rev Genet 2005; 6:766\u2013773.","journal-title":"Nat Rev Genet"},{"key":"16_CR150","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.tins.2008.09.004","volume":"31","author":"E Bossy-Wetzel","year":"2008","unstructured":"Bossy-Wetzel E, Petrilli A, Knott AB. Mutant huntingtin and mitochondrial dysfunction. Trends Neurosci 2008; 31:609\u2013616.","journal-title":"Trends Neurosci"},{"key":"16_CR151","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/j.1471-4159.2005.03411.x","volume":"95","author":"BG Jenkins","year":"2005","unstructured":"Jenkins BG, Andreassen OA, Dedeoglu A et al. Effects of CAG repeat length, HTT protein length and protein context on cerebral metabolism measured using magnetic resonance spectroscopy in transgenic mouse models of Huntington\u2019s disease. J Neurochem 2005; 95:553\u2013562.","journal-title":"J Neurochem"},{"key":"16_CR152","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/ana.410390317","volume":"39","author":"M Gu","year":"1996","unstructured":"Gu M, Gash MT, Mann VM et al. Mitochondrial defect in Huntington\u2019s disease caudate nucleus. Ann Neurol 1996; 39:385\u2013389.","journal-title":"Ann Neurol"},{"key":"16_CR153","doi-asserted-by":"publisher","first-page":"30773","DOI":"10.1074\/jbc.M504749200","volume":"280","author":"T Milakovic","year":"2005","unstructured":"Milakovic T, Johnson GV. Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant huntingtin. J Biol Chem 2005; 280:30773\u201330782.","journal-title":"J Biol Chem"},{"key":"16_CR154","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","volume":"5","author":"AV Panov","year":"2002","unstructured":"Panov AV, Gutekunst CA, Leavitt BR et al. Early mitochondrial calcium defects in Huntington\u2019s disease are a direct effect of polyglutamines. Nat Neurosci 2002; 5:731\u2013736.","journal-title":"Nat Neurosci"},{"key":"16_CR155","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/00019052-199512000-00014","volume":"8","author":"E Brouillet","year":"1995","unstructured":"Brouillet E, Hantraye P. Effects of chronic MPTP and 3-nitropropionic acid in nonhuman primates. Curr Opin Neurol 1995; 8:469\u2013473.","journal-title":"Curr Opin Neurol"},{"key":"16_CR156","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S0168-9525(01)02625-7","volume":"18","author":"DC Rubinsztein","year":"2002","unstructured":"Rubinsztein DC. Lessons from animal models of Huntington\u2019s disease. Trends Genet 2002; 18:202\u2013209.","journal-title":"Trends Genet"},{"key":"16_CR157","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S0166-2236(00)01721-5","volume":"24","author":"E Cattaneo","year":"2001","unstructured":"Cattaneo E, Rigamonti D, Goffredo D et al. Loss of normal huntingtin function: new developments in Huntington\u2019s disease research. Trends Neurosci 2001; 24:182\u2013188.","journal-title":"Trends Neurosci"},{"key":"16_CR158","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1385\/MN:23:1:21","volume":"23","author":"S Sipione","year":"2001","unstructured":"Sipione S, Cattaneo E. Modeling Huntington\u2019s disease in cells, flies and mice. Mol Neurobiol 2001; 23:21\u201351.","journal-title":"Mol Neurobiol"},{"key":"16_CR159","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s10571-007-9206-5","volume":"27","author":"MM Banoei","year":"2007","unstructured":"Banoei MM, Houshmand M, Panahi MS et al. Huntington\u2019s disease and mitochondrial DNA deletions: event or regular mechanism for mutant huntingtin protein and CAG repeats expansion?! Cell Mol Neurobiol 2007; 27:867\u2013875.","journal-title":"Cell Mol Neurobiol"},{"key":"16_CR160","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.dnarep.2008.09.004","volume":"8","author":"K Acevedo-Torres","year":"2009","unstructured":"Acevedo-Torres K, Berrios L, Rosario N et al. Mitochondrial DNA damage is a hallmark of chemically induced and the R6\/2 transgenic model of Huntington\u2019s disease. DNA Repair (Amst) 2009; 8:126\u2013136.","journal-title":"DNA Repair (Amst)"},{"key":"16_CR161","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.mad.2005.09.010","volume":"127","author":"F Squitieri","year":"2006","unstructured":"Squitieri F, Cannella M, Sgarbi G et al. Severe ultrastructural mitochondrial changes in lymphoblasts homozygous for Huntington disease mutation. Mech Ageing Dev 2006; 127:217\u2013220.","journal-title":"Mech Ageing Dev"},{"key":"16_CR162","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/cdd.2009.22","volume":"16","author":"G Liot","year":"2009","unstructured":"Liot G, Bossy B, Lubitz S et al. Complex II inhibition by 3-NP causes mitochondrial fragmentation and neuronal cell death via an NMDA-and ROS-dependent pathway. Cell Death Differ 2009; 16:899\u2013909.","journal-title":"Cell Death Differ"},{"key":"16_CR163","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/hmg\/ddn404","volume":"18","author":"H Wang","year":"2009","unstructured":"Wang H, Lim PJ, Karbowski M et al. Effects of overexpression of huntingtin proteins on mitochondrial integrity. Hum Mol Genet 2009; 18:737\u2013752.","journal-title":"Hum Mol Genet"},{"key":"16_CR164","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.nbd.2005.12.007","volume":"22","author":"DT Chang","year":"2006","unstructured":"Chang DT, Rintoul GL, Pandipati S et al. Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons. Neurobiol Dis 2006; 22:388\u2013400.","journal-title":"Neurobiol Dis"},{"key":"16_CR165","doi-asserted-by":"publisher","first-page":"8195","DOI":"10.1128\/MCB.24.18.8195-8209.2004","volume":"24","author":"E Trushina","year":"2004","unstructured":"Trushina E, Dyer RB, Badger JD, 2nd et al. Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro. Mol Cell Biol 2004; 24:8195\u20138209.","journal-title":"Mol Cell Biol"}],"container-title":["Advances in Experimental Medicine and Biology","Neurodegenerative Diseases"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4614-0653-2_16.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T05:36:56Z","timestamp":1713677816000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4614-0653-2_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"ISBN":["9781461406525","9781461406532"],"references-count":165,"URL":"https:\/\/doi.org\/10.1007\/978-1-4614-0653-2_16","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4614-0653-2","asserted-by":"object"}]},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}